Evaluating the Effect of Sage-718 on Cognitive Function in Participants with Huntington’s Disease
Enrolling By Invitation
25-65 years
All
4 participants needed
1 Location
Brief description of study
This is a study that evaluates SAGE-718 in participants with Huntington's Disease.
Detailed description of study
This is a study that evaluates SAGE-718 in participants with Huntington's Disease.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research, Huntington’s
-
Age: Between 25 Years - 65 Years
-
Gender: All
Age 25 to 65 Huntington's Disease
Updated on
01 Aug 2024.
Study ID: 851128
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
